Umar Farooq
Impact in
- Transplantation top 2%
- Renal Transplantation Outcomes and Treatments
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 29
-
- Renal Transplantation Outcomes and Treatments 15
- Co-authors
- Matthew J. Maurer (28 shared papers)James R. Cerhan (27 shared papers)Brian K. Link (20 shared papers)Sattva Swarup Neelapu (7 shared papers)Michael Crump (5 shared papers)John G. Kuruvilla (5 shared papers)Lynn Navale (6 shared papers)Christian Gisselbrecht (5 shared papers)
- Journals
- Blood (11 papers)Transplantation and Cellular Therapy (8 papers)Blood Advances (7 papers)Transplantation (7 papers)Hematological Oncology (5 papers)
- Partner nations
- United StatesPakistanChina
In The Last Decade
Umar Farooq
117 papers receiving 2.7k citations
Umar Farooq's Hit Papers
Peers
Comparison fields: 5 of 124
- Transplantation 180
- Pathology and Forensic Medicine 872
- Oncology 1.2k
- Genetics 227
- Hematology 163
Countries citing papers authored by Umar Farooq
This map shows the geographic impact of Umar Farooq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umar Farooq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umar Farooq more than expected).
Fields of papers citing papers by Umar Farooq
This network shows the impact of papers produced by Umar Farooq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umar Farooq. The network helps show where Umar Farooq may publish in the future.
Co-authors
The 25 scholars most cited alongside Umar Farooq, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study Hit paper breakdown → | 2017 | 1170 |
| 2 | 2013 | 164 | |
| 3 | JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma Hit paper breakdown → | 2024 | 107 |
| 4 | 2013 | 101 | |
| 5 | 2016 | 71 | |
| 6 | 2010 | 64 | |
| 7 | 2021 | 58 | |
| 8 | 2023 | 58 | |
| 9 | 2017 | 46 | |
| 10 | 2019 | 43 | |
| 11 | 2022 | 43 | |
| 12 | 2022 | 42 | |
| 13 | 2013 | 33 | |
| 14 | 2016 | 30 | |
| 15 | 2018 | 30 | |
| 16 | 2019 | 28 | |
| 17 | 2014 | 27 | |
| 18 | 2017 | 25 | |
| 19 | 2014 | 23 | |
| 20 | 2023 | 22 |
About Umar Farooq
Umar Farooq is a scholar working on Pathology and Forensic Medicine, Transplantation, Oncology, Genetics and Hematology, having authored 130 papers that have together received 2.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (29 papers), CAR-T cell therapy research (17 papers), Renal Transplantation Outcomes and Treatments (15 papers), CNS Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (11 papers), Multiple Myeloma Research and Treatments (7 papers), Acute Lymphoblastic Leukemia research (7 papers) and Viral-associated cancers and disorders (7 papers). The work is most often cited by research in Transplantation (180 citations), Pathology and Forensic Medicine (872 citations), Oncology (1.2k citations), Genetics (227 citations) and Hematology (163 citations). Umar Farooq has collaborated with scholars based in United States, Pakistan and China. Frequent co-authors include Matthew J. Maurer, James R. Cerhan, Brian K. Link, Sattva Swarup Neelapu, Michael Crump, John G. Kuruvilla, Lynn Navale, Christian Gisselbrecht, Jeff Wiezorek and Annette E. Hay. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Blood Advances, Transplantation and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.